nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice
|
Hwang, Shen-An |
|
2009 |
27 |
23 |
p. 3026-3034 9 p. |
artikel |
2 |
A prime–boost vaccination of mice with heterologous H5N1 strains
|
Ikeno, Daisuke |
|
2009 |
27 |
23 |
p. 3121-3125 5 p. |
artikel |
3 |
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
|
Sagara, Issaka |
|
2009 |
27 |
23 |
p. 3090-3098 9 p. |
artikel |
4 |
Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine
|
Galindo, Ruth C. |
|
2009 |
27 |
23 |
p. 3039-3044 6 p. |
artikel |
5 |
Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs
|
Jeuland, Marc |
|
2009 |
27 |
23 |
p. 3109-3120 12 p. |
artikel |
6 |
Do they accept compulsory vaccination?
|
Seale, Holly |
|
2009 |
27 |
23 |
p. 3022-3025 4 p. |
artikel |
7 |
Editorial Board
|
|
|
2009 |
27 |
23 |
p. CO2- 1 p. |
artikel |
8 |
Effectiveness of two pertussis vaccines in preterm Danish children
|
Hviid, Anders |
|
2009 |
27 |
23 |
p. 3035-3038 4 p. |
artikel |
9 |
Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses
|
Patel, Ami |
|
2009 |
27 |
23 |
p. 3083-3089 7 p. |
artikel |
10 |
Hepatitis C virus-specific T cell responses against conserved regions in recovered patients
|
Klade, C.S. |
|
2009 |
27 |
23 |
p. 3099-3108 10 p. |
artikel |
11 |
Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies
|
Le, Thuy T.T. |
|
2009 |
27 |
23 |
p. 3053-3062 10 p. |
artikel |
12 |
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
|
Demento, Stacey L. |
|
2009 |
27 |
23 |
p. 3013-3021 9 p. |
artikel |
13 |
Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
|
Baldwin, Susan L. |
|
2009 |
27 |
23 |
p. 3063-3071 9 p. |
artikel |
14 |
Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody
|
Abdel-Motal, Ussama M. |
|
2009 |
27 |
23 |
p. 3072-3082 11 p. |
artikel |
15 |
TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity
|
Johnson, Teresa R. |
|
2009 |
27 |
23 |
p. 3045-3052 8 p. |
artikel |